Results 211 to 220 of about 2,811,792 (409)
Angiotensin II receptor blockade in diabetic nephropathy [PDF]
Michael Ruddy
openalex +1 more source
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo +7 more
wiley +1 more source
Non-HLA Autoantibodies Against Angiotensin II Receptor 1 (AT1R) and Endothelin A Receptor (ETAR) in Pediatric Kidney Transplantation [PDF]
Benedetta Antoniello +6 more
openalex +1 more source
Angiotensin Receptor Neprilysin Inhibition (ARNi) Attenuates Adverse Cardiac Remodelling In Vitro and In Vivo [PDF]
Thomas von Lueder +7 more
openalex +1 more source
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk +12 more
wiley +1 more source
Impact of hypertension and angiotensin receptor blockers on colorectal cancer: A retrospective study. [PDF]
Rezazadeh M +7 more
europepmc +1 more source
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
J. Cohn, G. Tognoni
semanticscholar +1 more source
Abstract Aims Cardiac decompensation in cardiorenal syndrome (CRS) results in systemic congestion usually treated with diuretics. When despite high doses of diuretics, response is poor, ultrafiltration (UF) appears to be a useful and safe technique.
Borja Guerrero Cervera +12 more
wiley +1 more source
Angiotensin Receptor Blockers Are Not Associated With Protective Benefits in Dupuytren's Disease. [PDF]
Portney DA +4 more
europepmc +1 more source

